Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Revenue growth
Medtronic PLC's revenue growth over the twelve months to 31 July 2026 was 9.77%, up 1.3 percentage points from fiscal 2026 (8.43%). Over the past ten years it has ranged from −5.38% (fiscal 2020) to 42.3% (fiscal 2016); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of 8.80% and above the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 8.43% | 4.81 |
| FY2025 | 3.62% | (0.02) |
| FY2024 | 3.64% | 5.09 |
| FY2023 | −1.45% | (6.66) |
| FY2022 | 5.21% | 1.05 |
| FY2021 | 4.16% | 9.54 |
| FY2020 | −5.38% | (7.40) |
| FY2019 | 2.02% | 1.20 |
| FY2018 | 0.82% | (2.22) |
| FY2017 | 3.04% | (39.27) |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jul 2026 | 13.7% | 3.86 |
| Apr 2026 | 9.87% | 1.13 |
| Jan 2026 | 8.74% | 2.10 |
| Oct 2025 | 6.64% | (1.74) |
| 43 more quarters | Free account |
Against its own ten years
Low −5.38%
High 42.3%
Ten-year median
3.63%
Current reading's percentile
83
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| DXCM DexCom, Inc. compare | 15.5% |
| EW Edwards Lifesciences Corporation compare | 14.6% |
| BSX Boston Scientific Corporation compare | 13.5% |
| MDT Medtronic PLC | 9.77% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| SYK Stryker Corporation compare | 8.48% |
| STE STERIS plc compare | 8.37% |
| ABT Abbott Laboratories compare | 8.06% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement